View source for X-linked intellectual disability

{{Infobox medical condition (new)
| name            = X-linked intellectual disability
| synonyms        = X-linked mental retardation
| image           =
| caption         =
| pronounce       =
| field           =
| symptoms        =
| complications   =
| onset           =
| duration        =
| types           =
| causes          =
| risks           =
| diagnosis       =
| differential    =
| prevention      =
| treatment       =
| medication      =
| prognosis       =
| frequency       =
| deaths          =
}}
'''X-linked intellectual disability''' refers to medical disorders associated with [[X-linked recessive inheritance]] that result in [[intellectual disability]].

As with most X-linked disorders, males are more heavily affected than females.<ref>{{cite web |url=http://www.ibis-birthdefects.org/start/frafact.htm |title=Fragile X Syndrome - X-linked Mental Retardation and Macroorchidism |publisher=International Birth Defect Information Systems |access-date=2010-12-10}}</ref> Females with one affected [[X chromosome]] and one normal X chromosome tend to have milder symptoms.

Unlike many other types of intellectual disability, the genetics of these conditions are relatively well understood.<ref name="pmid15630421">{{cite journal | vauthors = Ropers HH, Hamel BC | title = X-linked mental retardation | journal = Nature Reviews. Genetics | volume = 6 | issue = 1 | pages = 46–57 | date = January 2005 | pmid = 15630421 | doi = 10.1038/nrg1501 | s2cid = 427210 }}</ref><ref name="pmid17873643">{{cite journal | vauthors = Lugtenberg D, Veltman JA, van Bokhoven H | title = High-resolution genomic microarrays for X-linked mental retardation | journal = Genetics in Medicine | volume = 9 | issue = 9 | pages = 560–565 | date = September 2007 | pmid = 17873643 | doi = 10.1097/GIM.0b013e318149e647 | doi-access = free }}</ref> It has been estimated there are ~200 genes involved in this syndrome; of these ~100 have been identified.<ref>{{cite journal | vauthors = Stevenson RE, Schwartz CE | title = X-linked intellectual disability: unique vulnerability of the male genome | journal = Developmental Disabilities Research Reviews | volume = 15 | issue = 4 | pages = 361–368 | year = 2009 | pmid = 20014364 | doi = 10.1002/ddrr.81 }}</ref> Many of these genes are found on the [[p arm|short 'p' arm]] of the chromosome, and [[Xp11.2 Duplication|duplications at Xp11.2]] are associated with the syndromic form of the condition.<ref>{{Cite web|url=https://omim.org/entry/300705|title=OMIM Entry - # 300705 - CHROMOSOME Xp11.22 DUPLICATION SYNDROME|website=omim.org|language=en-us|access-date=2018-03-09}}</ref><ref>{{Cite web|url=https://rarediseases.info.nih.gov/diseases/12766/microduplication-xp1122-p1123-syndrome|title=Microduplication Xp11.22-p11.23 syndrome {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program|website=rarediseases.info.nih.gov|language=en|access-date=2018-03-09}}</ref>

X-linked intellectual disability accounts for ~16% of all cases of intellectual disability in males.<ref>{{cite journal | vauthors = Stevenson RE, Schwartz CE | title = X-linked intellectual disability: unique vulnerability of the male genome | journal = Developmental Disabilities Research Reviews | volume = 15 | issue = 4 | pages = 361–368 | year = 2009 | pmid = 20014364 | doi = 10.1002/ddrr.81 }}</ref>

==Syndromes==
Several X-linked syndromes include intellectual disability as part of the presentation. These include:
* [[Coffin–Lowry syndrome]]
* [[DDX3X syndrome]]
* [[MASA syndrome]]
* [[MECP2 duplication syndrome]]
* [[Mental retardation and microcephaly with pontine and cerebellar hypoplasia]]
* [[X-linked alpha thalassemia mental retardation syndrome]]

==List of genes==
Following is a list of genes located on the X chromosome and linked to intellectual disability. There are also several loci that have not been associated with a specific gene.
* [[IQSEC2]]: encodes an exchange factor for the [[ADP ribosylation factor|Arf family]] of small GTP binding proteins, involved in the formation of secretory vesicles.<ref name="pmid20473311">{{cite journal | vauthors = Shoubridge C, Tarpey PS, Abidi F, Ramsden SL, Rujirabanjerd S, Murphy JA, Boyle J, Shaw M, Gardner A, Proos A, Puusepp H, Raymond FL, Schwartz CE, Stevenson RE, Turner G, Field M, Walikonis RS, Harvey RJ, Hackett A, Futreal PA, Stratton MR, Gécz J | display-authors = 6 | title = Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability | journal = Nature Genetics | volume = 42 | issue = 6 | pages = 486–488 | date = June 2010 | pmid = 20473311 | pmc = 3632837 | doi = 10.1038/ng.588 }}</ref>
* [[TM4SF2]]: is a member of the 4 transmembrane domains family of proteins ([[tetraspanin]]s, see [[TSPAN7]]). This gene is also associated with neuropsychiatric diseases such as [[Huntington's chorea]].<ref name="pmid12070254">{{cite journal | vauthors = Abidi FE, Holinski-Feder E, Rittinger O, Kooy F, Lubs HA, Stevenson RE, Schwartz CE | title = A novel 2 bp deletion in the TM4SF2 gene is associated with MRX58 | journal = Journal of Medical Genetics | volume = 39 | issue = 6 | pages = 430–433 | date = June 2002 | pmid = 12070254 | pmc = 1735161 | doi = 10.1136/jmg.39.6.430 }}</ref>
* [[AP1S2]]: AP-1 complex subunit sigma-2.<ref name="pmid17186471">{{cite journal | vauthors = Tarpey PS, Stevens C, Teague J, Edkins S, O'Meara S, Avis T, Barthorpe S, Buck G, Butler A, Cole J, Dicks E, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, West S, Widaa S, Yates A, Catford R, Butler J, Mallya U, Moon J, Luo Y, Dorkins H, Thompson D, Easton DF, Wooster R, Bobrow M, Carpenter N, Simensen RJ, Schwartz CE, Stevenson RE, Turner G, Partington M, Gecz J, Stratton MR, Futreal PA, Raymond FL | display-authors = 6 | title = Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation | journal = American Journal of Human Genetics | volume = 79 | issue = 6 | pages = 1119–1124 | date = December 2006 | pmid = 17186471 | pmc = 1698718 | doi = 10.1086/510137 }}</ref><ref name="entrez">{{cite web | work = Entrez Gene | title = AP1S2 adaptor-related protein complex 1, sigma 2 subunit | publisher = National Center for Biotechnology Information, U.S. National Library of Medicine |url=https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8905 }}</ref> Adaptor protein complex 1 is found on the cytoplasmic face of vesicles located at the [[Golgi complex]], where it mediates both the recruitment of [[clathrin]] to the membrane and the recognition of sorting signals within the cytosolic tails of transmembrane receptors.
* [[ACSL4]]: Long-chain-fatty-acid—CoA ligase 4 is an [[enzyme]] of the [[long-chain fatty-acid-coenzyme A ligase]] family.  It converts free [[long-chain fatty acid]]s into [[fatty acyl-CoA esters]], and thereby play a key role in [[lipid]] [[biosynthesis]] and fatty acid degradation.<ref name="pmid9480748">{{cite journal | vauthors = Piccini M, Vitelli F, Bruttini M, Pober BR, Jonsson JJ, Villanova M, Zollo M, Borsani G, Ballabio A, Renieri A | display-authors = 6 | title = FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation | journal = Genomics | volume = 47 | issue = 3 | pages = 350–358 | date = February 1998 | pmid = 9480748 | doi = 10.1006/geno.1997.5104 | doi-access = free }}</ref> This isozyme preferentially utilizes [[arachidonate]] as [[Substrate (biochemistry)|substrate]].
* [[ZNF41]]: Zinc finger protein 41  is a likely zinc finger family transcription factor.<ref name="pmid2037297">{{cite journal | vauthors = Franzè A, Archidiacono N, Rocchi M, Marino M, Grimaldi G | title = Isolation and expression analysis of a human zinc finger gene (ZNF41) located on the short arm of the X chromosome | journal = Genomics | volume = 9 | issue = 4 | pages = 728–736 | date = April 1991 | pmid = 2037297 | doi = 10.1016/0888-7543(91)90367-N }}</ref>
* [[DLG3]]: Disks large homolog 3,  also named  neuroendocrine-DLG or synapse-associated protein 102 (SAP-102).<ref name="pmid9598320">{{cite journal | vauthors = Stathakis DG, Lee D, Bryant PJ | title = DLG3, the gene encoding human neuroendocrine Dlg (NE-Dlg), is located within the 1.8-Mb dystonia-parkinsonism region at Xq13.1 | journal = Genomics | volume = 49 | issue = 2 | pages = 310–313 | date = April 1998 | pmid = 9598320 | doi = 10.1006/geno.1998.5243 }}</ref> DLG3 is a member of the [[membrane-associated guanylate kinase]] (MAGUK) superfamily.
* [[FTSJ1]]: Transfert RNA methyltransferase 1 is a member of the S-adenosylmethionine-binding protein family. This nucleolar protein is involved in the processing and modification of tRNA.<ref name="pmid15342698">{{cite journal | vauthors = Ramser J, Winnepenninckx B, Lenski C, Errijgers V, Platzer M, Schwartz CE, Meindl A, Kooy RF | display-authors = 6 | title = A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9) | journal = Journal of Medical Genetics | volume = 41 | issue = 9 | pages = 679–683 | date = September 2004 | pmid = 15342698 | pmc = 1735884 | doi = 10.1136/jmg.2004.019000 }}</ref><ref name="pmid25404562">{{cite journal | vauthors = Guy MP, Phizicky EM | title = Conservation of an intricate circuit for crucial modifications of the tRNAPhe anticodon loop in eukaryotes | journal = RNA | volume = 21 | issue = 1 | pages = 61–74 | date = January 2015 | pmid = 25404562 | pmc = 4274638 | doi = 10.1261/rna.047639.114 | name-list-style = amp }}</ref>
* [[GDI1]]: RabGDI alpha makes a complex with geranylgeranylated small GTP-binding proteins of the Rab family and keeps them in the cytosol.
* [[MECP2]]: methyl CpG binding protein 2  is a transcription regulator, which represses transcription from methylated gene promoters. It appears to be essential for the normal function of nerve cells.<ref>{{cite journal | vauthors = Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY | title = MeCP2, a key contributor to neurological disease, activates and represses transcription | journal = Science | volume = 320 | issue = 5880 | pages = 1224–1229 | date = May 2008 | pmid = 18511691 | pmc = 2443785 | doi = 10.1126/science.1153252 | bibcode = 2008Sci...320.1224C }}</ref> In contrast to other MBD family members, MECP2 is X-linked and subject to [[X inactivation]].  MECP2 gene mutations are the cause of most cases of [[Rett syndrome]], a progressive neurologic developmental disorder and one of the most common causes of intellectual disability in women.
* [[Aristaless related homeobox|ARX]]: Aristaless related homeobox, is a protein associated with [[intellectual disability]] and [[lissencephaly]]. This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is involved in CNS and pancreas development. Mutations in this gene cause X-linked intellectual disability and epilepsy.<ref>{{cite journal | vauthors = Bienvenu T, Poirier K, Friocourt G, Bahi N, Beaumont D, Fauchereau F, Ben Jeema L, Zemni R, Vinet MC, Francis F, Couvert P, Gomot M, Moraine C, van Bokhoven H, Kalscheuer V, Frints S, Gecz J, Ohzaki K, Chaabouni H, Fryns JP, Desportes V, Beldjord C, Chelly J | display-authors = 6 | title = ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation | journal = Human Molecular Genetics | volume = 11 | issue = 8 | pages = 981–991 | date = April 2002 | pmid = 11971879 | doi = 10.1093/hmg/11.8.981 | doi-access = free }}</ref>
* [[KDM5C]]: Lysine-specific demethylase 5C is an [[enzyme]] that in humans is encoded by the ''KDM5C'' [[gene]] a member of the SMCY homolog family and encodes a protein with one [[ARID domain]], one JmjC domain, one JmjN domain and two [[PHD finger|PHD-type zinc fingers]]. The DNA-binding motifs suggest this protein is involved in the regulation of transcription and chromatin remodeling.<ref>{{cite journal | vauthors = Jensen LR, Amende M, Gurok U, Moser B, Gimmel V, Tzschach A, Janecke AR, Tariverdian G, Chelly J, Fryns JP, Van Esch H, Kleefstra T, Hamel B, Moraine C, Gecz J, Turner G, Reinhardt R, Kalscheuer VM, Ropers HH, Lenzner S | display-authors = 6 | title = Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation | journal = American Journal of Human Genetics | volume = 76 | issue = 2 | pages = 227–236 | date = February 2005 | pmid = 15586325 | pmc = 1196368 | doi = 10.1086/427563 }}</ref>
* [[PHF8]]: PHD finger protein 8  belongs to the family of ferrous iron and [[2-oxoglutarate]] dependent [[oxygenases]],<ref>{{cite journal | vauthors = Loenarz C, Schofield CJ | title = Expanding chemical biology of 2-oxoglutarate oxygenases | journal = Nature Chemical Biology | volume = 4 | issue = 3 | pages = 152–156 | date = March 2008 | pmid = 18277970 | doi = 10.1038/nchembio0308-152 | author-link2 = Christopher J. Schofield }}</ref> and is a [[histone]] lysine demethylase with selectivity for the di-and monomethyl states.<ref name= "PMID19843542">{{cite journal | vauthors = Loenarz C, Ge W, Coleman ML, Rose NR, Cooper CD, Klose RJ, Ratcliffe PJ, Schofield CJ | display-authors = 6 | title = PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an Nepsilon-dimethyl lysine demethylase | journal = Human Molecular Genetics | volume = 19 | issue = 2 | pages = 217–222 | date = January 2010 | pmid = 19843542 | pmc = 4673897 | doi = 10.1093/hmg/ddp480 | author-link8 = Christopher J. Schofield }}</ref>
* [[Fragile mental retardation 2|FMR2]]: Fragile mental retardation 2  (FMR2: synonym AFF2),<ref name=Stettner2011>{{cite journal | vauthors = Stettner GM, Shoukier M, Höger C, Brockmann K, Auber B | title = Familial intellectual disability and autistic behavior caused by a small FMR2 gene deletion | journal = American Journal of Medical Genetics. Part A | volume = 155A | issue = 8 | pages = 2003–2007 | date = August 2011 | pmid = 21739600 | doi = 10.1002/ajmg.a.34122 | s2cid = 9568277 }}</ref> the protein belongs to the [[AF4/FMR2 family|AFF family]] which currently has four members: [[AFF1]]/AF4, AFF2/FMR2, [[AFF3]]/LAF4 and [[AFF4]]/AF5q31.<ref name=Melko2011>{{cite journal | vauthors = Melko M, Douguet D, Bensaid M, Zongaro S, Verheggen C, Gecz J, Bardoni B | title = Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability | journal = Human Molecular Genetics | volume = 20 | issue = 10 | pages = 1873–1885 | date = May 2011 | pmid = 21330300 | doi = 10.1093/hmg/ddr069 | doi-access = free }}</ref> All AFF proteins are localized in the nucleus and have a role as [[transcriptional activator]]s with a positive action on RNA elongation. AFF2/FMR2, AFF3/LAF4 and AFF4/AF5q31 localize in [[nuclear speckle]]s (subnuclear structures considered to be storage/modification sites of pre-mRNA splicing factors) and are able to bind RNA with a high apparent affinity for the G-quadruplex structure. They appear to modulate alternative splicing via the interaction with the G-quadruplex RNA-forming structure.
* [[SLC6A8|Slc6a8]]: Creatine transporter is a protein that is required for creatine to enter the cell.  Creatine is essential for maintaining ATP levels in cells with a high energy demand.<ref>{{cite journal | vauthors = Cecil KM, Salomons GS, Ball WS, Wong B, Chuck G, Verhoeven NM, Jakobs C, DeGrauw TJ | display-authors = 6 | title = Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? | journal = Annals of Neurology | volume = 49 | issue = 3 | pages = 401–404 | date = March 2001 | pmid = 11261517 | doi = 10.1002/ana.79 | s2cid = 38756630 }}</ref>
* [[GSPT2]]<ref>{{cite journal | vauthors = Grau C, Starkovich M, Azamian MS, Xia F, Cheung SW, Evans P, Henderson A, Lalani SR, Scott DA | display-authors = 6 | title = Xp11.22 deletions encompassing CENPVL1, CENPVL2, MAGED1 and GSPT2 as a cause of syndromic X-linked intellectual disability | journal = PLOS ONE | volume = 12 | issue = 4 | pages = e0175962 | year = 2017 | pmid = 28414775 | pmc = 5393878 | doi = 10.1371/journal.pone.0175962 | doi-access = free | bibcode = 2017PLoSO..1275962G }}</ref>
* [[MAGED1]]<ref>{{cite journal | vauthors = Grau C, Starkovich M, Azamian MS, Xia F, Cheung SW, Evans P, Henderson A, Lalani SR, Scott DA | display-authors = 6 | title = Xp11.22 deletions encompassing CENPVL1, CENPVL2, MAGED1 and GSPT2 as a cause of syndromic X-linked intellectual disability | journal = PLOS ONE | volume = 12 | issue = 4 | pages = e0175962 | year = 2017 | pmid = 28414775 | pmc = 5393878 | doi = 10.1371/journal.pone.0175962 | doi-access = free | bibcode = 2017PLoSO..1275962G }}</ref>
* [[UBE2A]]<ref>{{cite journal | vauthors = Czeschik JC, Bauer P, Buiting K, Dufke C, Guillén-Navarro E, Johnson DS, Koehler U, López-González V, Lüdecke HJ, Male A, Morrogh D, Rieß A, Tzschach A, Wieczorek D, Kuechler A | display-authors = 6 | title = X-linked intellectual disability type Nascimento is a clinically distinct, probably underdiagnosed entity | journal = Orphanet Journal of Rare Diseases | volume = 8 | pages = 146 | date = September 2013 | pmid = 24053514 | pmc = 4015352 | doi = 10.1186/1750-1172-8-146 | doi-access = free }}</ref>
* [[Protein O-GlcNAc transferase|OGT]]<ref>{{Cite journal |last=Mayfield |first=Johnathan M. |last2=Hitefield |first2=Naomi L. |last3=Czajewski |first3=Ignacy |last4=Vanhye |first4=Lotte |last5=Holden |first5=Laura |last6=Morava |first6=Eva |last7=van Aalten |first7=Daan M.F. |last8=Wells |first8=Lance |date=September 2024 |title=O-GlcNAc transferase congenital disorder of glycosylation (OGT-CDG): Potential mechanistic targets revealed by evaluating the OGT interactome |url=https://linkinghub.elsevier.com/retrieve/pii/S0021925824021008 |journal=Journal of Biological Chemistry |language=en |volume=300 |issue=9 |pages=107599 |doi=10.1016/j.jbc.2024.107599 |pmc=11381892 |pmid=39059494}}</ref><ref>{{Cite journal |last=Cheng |first=Steven S. |last2=Mody |first2=Alison C. |last3=Woo |first3=Christina M. |date=2024-11-07 |title=Opportunities for Therapeutic Modulation of O-GlcNAc |url=https://pubs.acs.org/doi/10.1021/acs.chemrev.4c00417 |journal=Chemical Reviews |language=en |doi=10.1021/acs.chemrev.4c00417 |issn=0009-2665|url-access=subscription }}</ref>

== See also ==
* [[Xp11.2 Duplication]]

== References ==
{{Reflist}}

== External links ==
{{Medical resources
|  DiseasesDB     =
|  ICD10          =
|  ICD9           =
|  ICDO           =
|  OMIM           =
|  MedlinePlus    =
|  eMedicineSubj  =
|  eMedicineTopic =
|  MeshID         = D038901
}}

{{X-linked disorders}}
{{Cell membrane protein disorders}}
{{Deficiencies of intracellular signaling peptides and proteins}}
{{Transcription factor/coregulator deficiencies}}
{{Vesicular transport protein disorders}}

[[Category:Intellectual disability]]
[[Category:X-linked recessive disorders]]